Imodium (Loperamide Hydrochloride)

Loperamide acts as a peripheral μ‑opioid receptor agonist in the gut. By binding to receptors in the myenteric plexus, it inhibits acetylcholine release, decreasing smooth‑muscle activity and slowing bowel movements. The slower transit allows more water to be absorbed, resulting in firmer stools.

The appropriate dose of Imodium is determined by a healthcare professional based on the individual’s condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount on the product label.

Safety data for loperamide in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare provider before using Imodium.

To order Imodium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details, and any required import documentation.

Imodium (loperamide) is a peripheral opioid agonist, whereas alternatives such as diphenoxylate‑atropine combine opioid activity with anticholinergic effects. Loperamide has minimal central nervous system penetration, reducing the risk of sedation, but both classes share similar efficacy in reducing stool frequency. Choice depends on patient profile, tolerance, and physician preference.

Imodium should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Imodium is taken orally, usually as a tablet swallowed with water. The exact administration schedule, including any repeat dosing, is set by the prescribing clinician based on the severity of symptoms and patient response.

Serious risks include severe constipation that can lead to bowel obstruction, toxic megacolon, and rare cardiac arrhythmias such as QT prolongation. If patients experience intense abdominal pain, vomiting, or signs of an allergic reaction, they should seek medical attention promptly.

Imodium should be avoided in individuals with known hypersensitivity to loperamide, in children younger than two years without medical guidance, and in patients with infectious diarrhea caused by bacteria, parasites, or toxins where slowing gut motility could worsen the condition. Caution is also advised for those with significant liver disease.